Core Insights - The cosmetics sector experienced a decline of 0.37% on December 9, with Jiaheng Jiahua leading the drop [1] - The Shanghai Composite Index closed at 3909.52, down 0.37%, while the Shenzhen Component Index closed at 13277.36, down 0.39% [1] Company Performance - Qing Song Co. (300132) saw a closing price of 8.17, with an increase of 4.34% and a trading volume of 475,200 shares, amounting to a transaction value of 383 million [1] - Kesheng Co. (300856) closed at 15.70, up 3.36%, with a trading volume of 158,000 shares and a transaction value of 252 million [1] - Jiaheng Jiahua (300955) closed at 36.00, down 2.91%, with a trading volume of 64,600 shares and a transaction value of 23.4 million [2] Capital Flow - The cosmetics sector experienced a net outflow of 88.18 million from main funds, while retail investors saw a net inflow of 55.04 million [2] - Main funds showed a net inflow in Qing Song Co. of 20.05 million, while Jiaheng Jiahua experienced a net outflow of 2.01 million [3] - Retail investors contributed a net inflow of 804.95 million to Shuiyang Co. (300740), while Qingdao Jinwang (002094) saw a net outflow of 264.27 million [3]

Group 1 - The cosmetics sector experienced a decline of 1.35% on December 5, with Qingdao Jinhao leading the drop [1] - The Shanghai Composite Index closed at 3902.81, up 0.7%, while the Shenzhen Component Index closed at 13147.68, up 1.08% [1] - Notable gainers in the cosmetics sector included Jinsong New Materials, which rose by 4.27% to a closing price of 16.10, and Qingsong Co., which increased by 4.10% to 7.61 [1] Group 2 - The cosmetics sector saw a net outflow of 58.93 million yuan from institutional investors, while retail investors had a net inflow of 101 million yuan [2] - Key stocks with significant retail inflows included Shanghai Jahwa, which had a retail net inflow of 8.45%, and Qingsong Co., with a retail net inflow of 6.08% [3] - Qingdao Jinhao experienced a net outflow of 59.69 million yuan from institutional investors, indicating a negative sentiment towards the stock [3]

Group 1 - The core point of the article is that Lafang Jiahua (603630) has reported a total of 18,382 shareholders as of September 30, 2025 [1]

Market Overview - On December 1, the cosmetics sector rose by 0.26% compared to the previous trading day, with BAWI leading the gains [1] - The Shanghai Composite Index closed at 3914.01, up 0.65%, while the Shenzhen Component Index closed at 13146.72, up 1.25% [1] Individual Stock Performance - BAWI shares closed at 15.93, up 2.38% with a trading volume of 16,900 lots and a transaction value of 26.70 million yuan [1] - Shanghai Jahwa closed at 23.61, up 1.77% with a trading volume of 49,400 lots and a transaction value of 116 million yuan [1] - Huachun Color closed at 28.22, up 1.00% with a trading volume of 16,000 lots and a transaction value of 45.40 million yuan [1] - Betaini closed at 41.52, up 0.56% with a trading volume of 27,900 lots and a transaction value of 116 million yuan [1] - Kohn shares closed at 16.44, up 0.55% with a trading volume of 161,900 lots and a transaction value of 263 million yuan [1] - Proya closed at 70.61, up 0.37% with a trading volume of 23,200 lots and a transaction value of 163 million yuan [1] - Qingdao King closed at 7.38, up 0.27% with a trading volume of 85,100 lots and a transaction value of 6.28 million yuan [1] - Marubi closed at 35.47, up 0.11% with a trading volume of 29,300 lots and a transaction value of 103 million yuan [1] - Lafang closed at 20.95, unchanged with a trading volume of 23,000 lots and a transaction value of 4.81 million yuan [1] - Qingsong shares closed at 7.53, down 0.13% with a trading volume of 129,100 lots and a transaction value of 96.89 million yuan [1] Fund Flow Analysis - The cosmetics sector experienced a net outflow of 49.52 million yuan from institutional funds, while retail investors saw a net inflow of 51.08 million yuan [2] - The overall fund flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are increasing their positions [2] Detailed Fund Flow by Stock - Jiahen Home's main funds saw a net inflow of 7.25 million yuan, while retail funds had a net outflow of 19.70 million yuan [3] - Shanghai Jahwa experienced a net inflow of 3.64 million yuan from main funds, with retail investors contributing a net inflow of 348.90 million yuan [3] - Kohn shares had a net inflow of 3.35 million yuan from main funds, but retail investors saw a net outflow [3] - BAWI experienced a net outflow of 0.50 million yuan from main funds, while retail investors had a net inflow of 164.42 million yuan [3] - Qingdao King saw a net outflow of 0.83 million yuan from main funds, but retail investors contributed a net inflow of 238.25 million yuan [3]

证券代码：603630 证券简称：拉芳家化 公告编号：2025-048 拉芳家化股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 拉芳家化股份有限公司（以下简称"公司"）于2025年4月28日召开第五届董事会第二次会议和2025年6月 9日召开2024年年度股东大会，审议通过了《关于续聘公司2025年度财务审计机构的议案》，同意续聘 华兴会计师事务所(特殊普通合伙)（以下简称"华兴"）为公司2025年度财务审计机构。具体内容详见公 司分别于2025年4月29日、2025年6月10日在上海证券交易所网站（www.sse.com.cn）披露的《关于续聘 公司2025年度财务审计机构的公告》（公告编号：2025-018）和《2024年年度股东大会决议公告》（公 告编号：2025-029）。 2025年11月28日，公司收到华兴出具的《关于变更签字注册会计师的函》，现将相关变更情况公告如 下： 一、签字注册会计师变更情况 华兴作为公司2025年度财务报表和2025年12月31日内部控制审 ...

证券代码：603630 证券简称：拉芳家化 公告编号：2025-048 拉芳家化股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 拉芳家化股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第五届董 事会第二次会议和 2025 年 6 月 9 日召开 2024 年年度股东大会，审议通过了《关于续 聘公司 2025 年度财务审计机构的议案》，同意续聘华兴会计师事务所(特殊普通合伙) （以下简称"华兴"）为公司 2025 年度财务审计机构。具体内容详见公司分别于 2025 年 4 月 29 日、2025 年 6 月 10 日在上海证券交易所网站（www.sse.com.cn）披露的《关 于续聘公司 2025 年度财务审计机构的公告》（公告编号：2025-018）和《2024 年年度 股东大会决议公告》（公告编号：2025-029）。 2025 年 11 月 28 日，公司收到华兴出具的《关于变更签字注册会计师的函》，现 将相关变更情况公告如下： 一、签字注册会计师变 ...

Group 1 - The cosmetics sector increased by 0.29% on November 28, with Jiaheng Jiahua leading the gains [1] - The Shanghai Composite Index closed at 3888.6, up 0.34%, while the Shenzhen Component Index closed at 12984.08, up 0.85% [1] - Jiaheng Jiahua's stock price rose by 6.45% to 40.28, with a trading volume of 67,100 shares and a transaction value of 266 million yuan [1] Group 2 - The cosmetics sector experienced a net outflow of 61.04 million yuan from institutional investors, while retail investors saw a net inflow of 76.64 million yuan [2] - Among individual stocks, Marubi Biological had a net outflow of 9.46 million yuan from institutional investors, while Shanghai Jahwa saw a net inflow of 5.63 million yuan [3] - The overall trading activity in the cosmetics sector indicates a mixed sentiment, with some stocks experiencing significant outflows while others attracted retail interest [2][3]

Core Viewpoint - The cosmetics sector experienced a 1.6% increase on November 27, with Keshare leading the gains, while the overall market showed mixed results with the Shanghai Composite Index rising by 0.29% and the Shenzhen Component Index declining by 0.25% [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3875.26, up 0.29% [1] - The Shenzhen Component Index closed at 12875.19, down 0.25% [1] - The cosmetics sector's individual stock performance is detailed in a table, highlighting significant gainers such as Keshare with a 9.12% increase [1] Group 2: Individual Stock Performance - Keshare (300856) closed at 16.15 with a 9.12% increase and a trading volume of 310,700 shares, amounting to a transaction value of 489 million yuan [1] - Marubi Biological (603983) closed at 35.19, up 4.89%, with a trading volume of 87,200 shares and a transaction value of 304 million yuan [1] - Other notable performers include Water Sheep (300740) with a 2.72% increase and a transaction value of 580 million yuan [1] Group 3: Capital Flow Analysis - The cosmetics sector saw a net outflow of 25.34 million yuan from institutional investors and 82.57 million yuan from retail investors, while individual investors contributed a net inflow of 108 million yuan [2] - A detailed table shows the capital flow for individual stocks, indicating that LaFang (603630) had a net inflow of 5.96 million yuan from institutional investors [3] - Other stocks like Shanghai Jahwa (600315) and Huaye Fragrance (300886) also experienced varying degrees of net inflow and outflow from different investor categories [3]

Market Overview - The cosmetics sector experienced a decline of 1.1% on November 26, with Kesheng Co. leading the drop [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] Individual Stock Performance - Notable gainers included: - Shuiyang Co. (300740) with a closing price of 19.85, up 2.58% [1] - Fulejia (301371) also rose by 2.58% to 27.88 [1] - Major decliners included: - Kesheng Co. (300856) fell by 4.88% to 14.80 [2] - Marubi Bio (603983) decreased by 2.95% to 33.55 [2] - Jiahen Home (300955) dropped by 2.85% to 37.84 [2] Trading Volume and Capital Flow - The cosmetics sector saw a net inflow of 7.95 million yuan from institutional investors, while retail investors contributed a net inflow of 7.35 million yuan [2] - However, there was a net outflow of 15.30 million yuan from speculative funds [2] Detailed Capital Flow Analysis - Key stocks with significant capital flow: - Jiahen Home (300955) had a net inflow of 18.65 million yuan from institutional investors, but a net outflow of 19.54 million yuan from retail investors [3] - Fulejia (301371) saw a net inflow of 12.12 million yuan from speculative funds, despite a net outflow from retail investors [3] - Other stocks like Qingdao King (002094) and Shanghai Jahwa (600315) also experienced mixed capital flows, indicating varied investor sentiment [3]

Core Insights - The article discusses the declining performance of traditional Chinese hair care brands, specifically Lafang, Mingchen Health, and Bawang Group, which have seen significant drops in revenue and profit despite a growing market for hair care products [1][2][3]. Group 1: Market Overview - The hair care market is projected to reach 899.95 billion yuan in 2024, with a year-on-year growth of 59.32%, indicating a positive outlook for the industry overall [1]. - Despite the optimistic market growth, traditional brands are struggling to maintain their market share and profitability [2]. Group 2: Revenue Performance - Lafang's revenue peaked at 1.101 billion yuan in 2021 but has since declined, reaching 860 million yuan in 2023, with a slight projected increase to 889 million yuan in 2024 [6]. - Mingchen Health has shown a more favorable trend, with revenue increasing from 681 million yuan in 2020 to 1.638 billion yuan in 2023, although it is expected to drop by 15.71% in 2024 [6]. - Bawang Group has consistently lagged behind, with revenue hovering around 250 million yuan, experiencing a decline from 2021 to 2023, but showing a potential recovery with a 9.33% increase in the first half of 2025 [6]. Group 3: Profitability Challenges - Lafang's net profit fluctuated significantly, peaking at 117 million yuan in 2020 but dropping to 41 million yuan in 2024, with a 77.01% decrease in the first three quarters of 2025 [10][11]. - Mingchen Health's net profit has been volatile, with a peak of 102 million yuan in 2020, followed by a drop to 25 million yuan in 2022, and a rebound to 70 million yuan in 2023, but again declining to 47 million yuan in 2024 [10][11]. - Bawang Group has faced continuous losses, with net profit of 14 million yuan in 2023, but falling to 7 million yuan in 2024, and a loss of 3 million yuan in the first half of 2025 [12]. Group 4: Gross Margin Trends - Lafang's gross margin has shown volatility, decreasing from 48.37% in 2020 to 47.18% in 2022, then recovering to 48.49% in the first three quarters of 2025 [15]. - Mingchen Health's gross margin peaked at 60.27% in 2023 but fell to 52.50% in 2024 due to rising raw material costs [16]. - Bawang Group's gross margin has been low, ranging from 36.20% to 39.17% from 2020 to 2022, but increased to 50.38% in 2023 before dropping to 43.95% in the first half of 2025 [16]. Group 5: R&D Investment - Mingchen Health has led in R&D investment, peaking at 99 million yuan in 2021 but dropping to 40 million yuan in the first three quarters of 2025 [20][21]. - Lafang's R&D investment has remained stable around 30-40 million yuan, but decreased to 23 million yuan in 2025 due to revenue decline [20][21]. - Bawang Group's R&D investment has been the lowest, consistently below 15 million yuan, indicating a lack of innovation [20][21]. Group 6: Brand Strategy and Market Position - Lafang's main brand continues to dominate, accounting for 80.41% of total revenue in the first half of 2025, but other brands have not made significant contributions [26]. - Mingchen Health's focus on gaming has led to a delay in updating its hair care brands, resulting in marginalization of its traditional products [26]. - Bawang Group's reliance on traditional products has left it vulnerable to competition from both established and emerging brands [26]. Group 7: Industry Challenges - The article identifies four main challenges for these traditional brands: product iteration lag, lack of user engagement, pressure from domestic and international brands, and quality compliance issues [27][31][35]. - The emergence of new brands and changing consumer preferences have intensified competition, particularly on platforms like Douyin [28][31].